Axogen Toekomstige groei
Future criteriumcontroles 4/6
Axogen is forecast to grow earnings and revenue by 79.4% and 11.8% per annum respectively while EPS is expected to grow by 81% per annum.
Belangrijke informatie
79.4%
Groei van de winst
81.0%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 22.8% |
| Inkomstengroei | 11.8% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 15 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 232 | 14 | 32 | N/A | 4 |
| 12/31/2025 | 208 | 0 | 7 | -5 | 6 |
| 12/31/2024 | 185 | -15 | 2 | 0 | 6 |
| 6/30/2024 | 173 | -17 | -15 | -7 | N/A |
| 3/31/2024 | 164 | -21 | -22 | -11 | N/A |
| 12/31/2023 | 159 | -22 | -21 | -6 | N/A |
| 9/30/2023 | 152 | -23 | -24 | -4 | N/A |
| 6/30/2023 | 148 | -23 | -27 | -6 | N/A |
| 3/31/2023 | 144 | -25 | -33 | -12 | N/A |
| 12/31/2022 | 139 | -29 | -37 | -16 | N/A |
| 9/30/2022 | 134 | -29 | -41 | -19 | N/A |
| 6/30/2022 | 128 | -32 | -45 | -19 | N/A |
| 3/31/2022 | 127 | -32 | -44 | -14 | N/A |
| 12/31/2021 | 127 | -27 | -42 | -13 | N/A |
| 9/30/2021 | 128 | -28 | -34 | -9 | N/A |
| 6/30/2021 | 131 | -22 | -27 | -6 | N/A |
| 3/31/2021 | 119 | -22 | -33 | -12 | N/A |
| 12/31/2020 | 112 | -24 | -32 | -10 | N/A |
| 9/30/2020 | 108 | -25 | -36 | -16 | N/A |
| 6/30/2020 | 103 | -29 | -37 | -20 | N/A |
| 3/31/2020 | 108 | -28 | -29 | -19 | N/A |
| 12/31/2019 | 107 | -29 | -25 | -20 | N/A |
| 9/30/2019 | 102 | -27 | -26 | -22 | N/A |
| 6/30/2019 | 96 | -26 | -30 | -23 | N/A |
| 3/31/2019 | 90 | -26 | -27 | -21 | N/A |
| 12/31/2018 | 84 | -22 | -24 | -18 | N/A |
| 9/30/2018 | 77 | -20 | -21 | -14 | N/A |
| 6/30/2018 | 71 | -18 | -15 | -13 | N/A |
| 3/31/2018 | 65 | -12 | N/A | -11 | N/A |
| 12/31/2017 | 60 | -10 | N/A | -9 | N/A |
| 9/30/2017 | 55 | -14 | N/A | -10 | N/A |
| 6/30/2017 | 50 | -14 | N/A | -10 | N/A |
| 3/31/2017 | 45 | -14 | N/A | -11 | N/A |
| 12/31/2016 | 41 | -14 | N/A | -11 | N/A |
| 9/30/2016 | 38 | -12 | N/A | -14 | N/A |
| 6/30/2016 | 34 | -13 | N/A | -14 | N/A |
| 3/31/2016 | 30 | -13 | N/A | -15 | N/A |
| 12/31/2015 | 27 | -13 | N/A | -13 | N/A |
| 9/30/2015 | 24 | -16 | N/A | -11 | N/A |
| 6/30/2015 | 21 | -16 | N/A | -11 | N/A |
| 3/31/2015 | 19 | -17 | N/A | -10 | N/A |
| 12/31/2014 | 17 | -18 | N/A | -10 | N/A |
| 9/30/2014 | 15 | -15 | N/A | -10 | N/A |
| 6/30/2014 | 13 | -16 | N/A | -11 | N/A |
| 3/31/2014 | 12 | -15 | N/A | -11 | N/A |
| 12/31/2013 | 11 | -15 | N/A | -10 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 0HKD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Winst versus markt: 0HKD is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hoge groeiwinsten: 0HKD is expected to become profitable in the next 3 years.
Omzet versus markt: 0HKD's revenue (11.8% per year) is forecast to grow faster than the UK market (3.6% per year).
Hoge groei-inkomsten: 0HKD's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 0HKD's Return on Equity is forecast to be high in 3 years time